Medicines Patent Pool Foundation
Medicines Patent Pool welcomes the WHO RoadMap for Access to medicines, vaccines and other health products. One of the deliverables which is anticipated to have significant impact on fostering innovation and access to health products is promotion of public health-oriented licensing agreements and transparency regarding patent status of existing and new health technologies. We agree that for licensing to become an effective vehicle for access, it must closely align with public health principles and be a part of a broader public health approach to improving access to safe, effective and affordable essential medicines.Over the past 9years, MPP is proud to have become a key driver of public health-oriented and transparent licensing agreements for improved access to medicines in LMICs. Over 100 countries have already benefited from access to new HIV and hepC treatments at affordable prices and in suitable formulations.
In support of the Roadmap’s deliverable on transparency of patent status of essential medicines, MedsPaL, our Patents&Licenses database, provides free patent, licensing and regulatory data exclusivity information on WHO essential medicines in LMICs. This has been possible thanks to close collaboration with national and regional patent offices who provide this data to us on a regular basis. We would like to invite other member states to join this important initiative to implement this deliverable. Finally, we welcome the deliverable supporting MPP’s expansion to other patented essential medicines included in WHO treatment guidelines through identification of potential products for licensing. Following strong support from Member States at the 71st WHA, MPP issued last week a framework to identify candidate products for licensing, working closely with the WHO and in consultation with other stakeholders. Further collaboration with all stakeholders will be extremely important. We look forward to collaboration with the Secretariat and the Member States.